Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1996 Jun;60(6):599–603. doi: 10.1136/jnnp.60.6.599

Multifocal motor neuropathy.

E Nobile-Orazio
PMCID: PMC1073940  PMID: 8648324

Full text

PDF
599

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D., Kuntzer T., Burger D., Chofflon M., Magistris M. R., Regli F., Steck A. J. Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera. J Neuroimmunol. 1991 Jun;32(3):223–230. doi: 10.1016/0165-5728(91)90192-a. [DOI] [PubMed] [Google Scholar]
  2. Arasaki K., Kusunoki S., Kudo N., Kanazawa I. Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve. 1993 Jun;16(6):587–593. doi: 10.1002/mus.880160603. [DOI] [PubMed] [Google Scholar]
  3. Auer R. N., Bell R. B., Lee M. A. Neuropathy with onion bulb formations and pure motor manifestations. Can J Neurol Sci. 1989 May;16(2):194–197. doi: 10.1017/s0317167100028894. [DOI] [PubMed] [Google Scholar]
  4. Azulay J. P., Blin O., Pouget J., Boucraut J., Billé-Turc F., Carles G., Serratrice G. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study. Neurology. 1994 Mar;44(3 Pt 1):429–432. doi: 10.1212/wnl.44.3_part_1.429. [DOI] [PubMed] [Google Scholar]
  5. Block B. M., Jones S. W. Delayed rectifier current of bullfrog sympathetic neurons: ion-ion competition, asymmetrical block and effects of ions on gating. J Physiol. 1997 Mar 1;499(Pt 2):403–416. doi: 10.1113/jphysiol.1997.sp021937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bouche P., Moulonguet A., Younes-Chennoufi A. B., Adams D., Baumann N., Meininger V., Léger J. M., Said G. Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry. 1995 Jul;59(1):38–44. doi: 10.1136/jnnp.59.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chad D. A., Hammer K., Sargent J. Slow resolution of multifocal weakness and fasciculation: a reversible motor neuron syndrome. Neurology. 1986 Sep;36(9):1260–1263. doi: 10.1212/wnl.36.9.1260. [DOI] [PubMed] [Google Scholar]
  8. Chaudhry V., Corse A. M., Cornblath D. R., Kuncl R. W., Drachman D. B., Freimer M. L., Miller R. G., Griffin J. W. Multifocal motor neuropathy: response to human immune globulin. Ann Neurol. 1993 Mar;33(3):237–242. doi: 10.1002/ana.410330303. [DOI] [PubMed] [Google Scholar]
  9. Chaudhry V., Corse A. M., Cornblath D. R., Kuncl R. W., Freimer M. L., Griffin J. W. Multifocal motor neuropathy: electrodiagnostic features. Muscle Nerve. 1994 Feb;17(2):198–205. doi: 10.1002/mus.880170211. [DOI] [PubMed] [Google Scholar]
  10. Comi G., Amadio S., Galardi G., Fazio R., Nemni R. Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy. J Neurol Neurosurg Psychiatry. 1994 Nov;57 (Suppl):35–37. doi: 10.1136/jnnp.57.suppl.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Di Bella P., Logullo F., Dionisi L., Danni M., Scarpelli M., Angeleri F. Chronic multifocal demyelinating neuropathy simulating motor neuron disease. Ital J Neurol Sci. 1991 Feb;12(1):113–118. doi: 10.1007/BF02337624. [DOI] [PubMed] [Google Scholar]
  12. Donaghy M., Mills K. R., Boniface S. J., Simmons J., Wright I., Gregson N., Jacobs J. Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry. 1994 Jul;57(7):778–783. doi: 10.1136/jnnp.57.7.778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dwyer J. M. Manipulating the immune system with immune globulin. N Engl J Med. 1992 Jan 9;326(2):107–116. doi: 10.1056/NEJM199201093260206. [DOI] [PubMed] [Google Scholar]
  14. Elliott J. L., Pestronk A. Progression of multifocal motor neuropathy during apparently successful treatment with human immunoglobulin. Neurology. 1994 May;44(5):967–968. doi: 10.1212/wnl.44.5.967. [DOI] [PubMed] [Google Scholar]
  15. Feasby T. E., Brown W. F., Gilbert J. J., Hahn A. F. The pathological basis of conduction block in human neuropathies. J Neurol Neurosurg Psychiatry. 1985 Mar;48(3):239–244. doi: 10.1136/jnnp.48.3.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Feldman E. L., Bromberg M. B., Albers J. W., Pestronk A. Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol. 1991 Sep;30(3):397–401. doi: 10.1002/ana.410300312. [DOI] [PubMed] [Google Scholar]
  17. Hartung H. P., Pollard J. D., Harvey G. K., Toyka K. V. Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I. Muscle Nerve. 1995 Feb;18(2):137–153. doi: 10.1002/mus.880180202. [DOI] [PubMed] [Google Scholar]
  18. Harvey G. K., Toyka K. V., Zielasek J., Kiefer R., Simonis C., Hartung H. P. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer. Muscle Nerve. 1995 Apr;18(4):388–394. doi: 10.1002/mus.880180404. [DOI] [PubMed] [Google Scholar]
  19. Kaji R., Oka N., Tsuji T., Mezaki T., Nishio T., Akiguchi I., Kimura J. Pathological findings at the site of conduction block in multifocal motor neuropathy. Ann Neurol. 1993 Feb;33(2):152–158. doi: 10.1002/ana.410330204. [DOI] [PubMed] [Google Scholar]
  20. Kaji R., Shibasaki H., Kimura J. Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy. Neurology. 1992 Mar;42(3 Pt 1):506–509. doi: 10.1212/wnl.42.3.506. [DOI] [PubMed] [Google Scholar]
  21. Kermode A. G., Laing B. A., Carroll W. M., Mastaglia F. L. Intravenous immunoglobulin for multifocal motor neuropathy. Lancet. 1992 Oct 10;340(8824):920–921. doi: 10.1016/0140-6736(92)93339-o. [DOI] [PubMed] [Google Scholar]
  22. Kinsella L. J., Lange D. J., Trojaborg W., Sadiq S. A., Younger D. S., Latov N. Clinical and electrophysiologic correlates of elevated anti-GM1 antibody titers. Neurology. 1994 Jul;44(7):1278–1282. doi: 10.1212/wnl.44.7.1278. [DOI] [PubMed] [Google Scholar]
  23. Kornberg A. J., Pestronk A. Chronic motor neuropathies: diagnosis, therapy, and pathogenesis. Ann Neurol. 1995 May;37 (Suppl 1):S43–S50. doi: 10.1002/ana.410370706. [DOI] [PubMed] [Google Scholar]
  24. Kornberg A. J., Pestronk A. The clinical and diagnostic role of anti-GM1 antibody testing. Muscle Nerve. 1994 Jan;17(1):100–104. doi: 10.1002/mus.880170115. [DOI] [PubMed] [Google Scholar]
  25. Krarup C., Stewart J. D., Sumner A. J., Pestronk A., Lipton S. A. A syndrome of asymmetric limb weakness with motor conduction block. Neurology. 1990 Jan;40(1):118–127. doi: 10.1212/wnl.40.1.118. [DOI] [PubMed] [Google Scholar]
  26. Krendel D. A., Costigan D. A. Multifocal motor neuropathy or CIDP? Ann Neurol. 1993 Nov;34(5):750–751. doi: 10.1002/ana.410340525. [DOI] [PubMed] [Google Scholar]
  27. Lamb N. L., Patten B. M. Clinical correlations of anti-GM1 antibodies in amyotrophic lateral sclerosis and neuropathies. Muscle Nerve. 1991 Oct;14(10):1021–1027. doi: 10.1002/mus.880141014. [DOI] [PubMed] [Google Scholar]
  28. Lange D. J., Trojaborg W. Do GM1 antibodies induce demyelination? Muscle Nerve. 1994 Jan;17(1):105–107. doi: 10.1002/mus.880170116. [DOI] [PubMed] [Google Scholar]
  29. Lange D. J., Trojaborg W., Latov N., Hays A. P., Younger D. S., Uncini A., Blake D. M., Hirano M., Burns S. M., Lovelace R. E. Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? Neurology. 1992 Mar;42(3 Pt 1):497–505. doi: 10.1212/wnl.42.3.497. [DOI] [PubMed] [Google Scholar]
  30. Lange D. J., Trojaborg W., McDonald T. D., Blake D. M. Persistent and transient "conduction block" in motor neuron diseases. Muscle Nerve. 1993 Sep;16(9):896–903. doi: 10.1002/mus.880160903. [DOI] [PubMed] [Google Scholar]
  31. Latov N., Hays A. P., Donofrio P. D., Liao J., Ito H., McGinnis S., Konstadoulakis M., Freddo L., Shy M. E., Manoussos K. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease. Neurology. 1988 May;38(5):763–768. doi: 10.1212/wnl.38.5.763. [DOI] [PubMed] [Google Scholar]
  32. Lewis R. A., Sumner A. J., Brown M. J., Asbury A. K. Multifocal demyelinating neuropathy with persistent conduction block. Neurology. 1982 Sep;32(9):958–964. doi: 10.1212/wnl.32.9.958. [DOI] [PubMed] [Google Scholar]
  33. Magistris M., Roth G. Motor neuropathy with multifocal persistent conduction blocks. Muscle Nerve. 1992 Sep;15(9):1056–1057. [PubMed] [Google Scholar]
  34. Nobile-Orazio E., Legname G., Daverio R., Carpo M., Giuliani A., Sonnino S., Scarlato G. Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b, and high-molecular-weight neural-specific glycoproteins. Ann Neurol. 1990 Aug;28(2):190–194. doi: 10.1002/ana.410280215. [DOI] [PubMed] [Google Scholar]
  35. Nobile-Orazio E., Meucci N., Barbieri S., Carpo M., Scarlato G. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology. 1993 Mar;43(3 Pt 1):537–544. doi: 10.1212/wnl.43.3_part_1.537. [DOI] [PubMed] [Google Scholar]
  36. Ogawa-Goto K., Funamoto N., Abe T., Nagashima K. Different ceramide compositions of gangliosides between human motor and sensory nerves. J Neurochem. 1990 Nov;55(5):1486–1493. doi: 10.1111/j.1471-4159.1990.tb04930.x. [DOI] [PubMed] [Google Scholar]
  37. Oh S. J., Claussen G. C., Odabasi Z., Palmer C. P. Multifocal demyelinating motor neuropathy: pathologic evidence of 'inflammatory demyelinating polyradiculoneuropathy'. Neurology. 1995 Oct;45(10):1828–1832. doi: 10.1212/wnl.45.10.1828. [DOI] [PubMed] [Google Scholar]
  38. Parry G. J. Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy. Muscle Nerve. 1994 Jan;17(1):97–99. doi: 10.1002/mus.880170114. [DOI] [PubMed] [Google Scholar]
  39. Parry G. J., Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve. 1988 Feb;11(2):103–107. doi: 10.1002/mus.880110203. [DOI] [PubMed] [Google Scholar]
  40. Pestronk A., Chaudhry V., Feldman E. L., Griffin J. W., Cornblath D. R., Denys E. H., Glasberg M., Kuncl R. W., Olney R. K., Yee W. C. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol. 1990 Mar;27(3):316–326. doi: 10.1002/ana.410270314. [DOI] [PubMed] [Google Scholar]
  41. Pestronk A., Cornblath D. R., Ilyas A. A., Baba H., Quarles R. H., Griffin J. W., Alderson K., Adams R. N. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol. 1988 Jul;24(1):73–78. doi: 10.1002/ana.410240113. [DOI] [PubMed] [Google Scholar]
  42. Pestronk A., Lopate G., Kornberg A. J., Elliott J. L., Blume G., Yee W. C., Goodnough L. T. Distal lower motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide. Neurology. 1994 Nov;44(11):2027–2031. doi: 10.1212/wnl.44.11.2028. [DOI] [PubMed] [Google Scholar]
  43. Rhee E. K., England J. D., Sumner A. J. A computer simulation of conduction block: effects produced by actual block versus interphase cancellation. Ann Neurol. 1990 Aug;28(2):146–156. doi: 10.1002/ana.410280206. [DOI] [PubMed] [Google Scholar]
  44. Roth G., Rohr J., Magistris M. R., Ochsner F. Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Evolution to tetraplegia. Eur Neurol. 1986;25(6):416–423. doi: 10.1159/000116045. [DOI] [PubMed] [Google Scholar]
  45. Sadiq S. A., Thomas F. P., Kilidireas K., Protopsaltis S., Hays A. P., Lee K. W., Romas S. N., Kumar N., van den Berg L., Santoro M. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology. 1990 Jul;40(7):1067–1072. doi: 10.1212/wnl.40.7.1067. [DOI] [PubMed] [Google Scholar]
  46. Salazar-Grueso E. F., Routbort M. J., Martin J., Dawson G., Roos R. P. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants. Ann Neurol. 1990 May;27(5):558–563. doi: 10.1002/ana.410270517. [DOI] [PubMed] [Google Scholar]
  47. Santoro M., Thomas F. P., Fink M. E., Lange D. J., Uncini A., Wadia N. H., Latov N., Hays A. P. IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block. Ann Neurol. 1990 Sep;28(3):373–377. doi: 10.1002/ana.410280312. [DOI] [PubMed] [Google Scholar]
  48. Santoro M., Uncini A., Corbo M., Staugaitis S. M., Thomas F. P., Hays A. P., Latov N. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol. 1992 Apr;31(4):385–390. doi: 10.1002/ana.410310407. [DOI] [PubMed] [Google Scholar]
  49. Shy M. E., Heiman-Patterson T., Parry G. J., Tahmoush A., Evans V. A., Schick P. K. Lower motor neuron disease in a patient with autoantibodies against Gal(beta 1-3)GalNAc in gangliosides GM1 and GD1b: improvement following immunotherapy. Neurology. 1990 May;40(5):842–844. doi: 10.1212/wnl.40.5.842. [DOI] [PubMed] [Google Scholar]
  50. Sumner A. J. Separating motor neuron diseases from pure motor neuropathies. Multifocal motor neuropathy with persistent conduction block. Adv Neurol. 1991;56:399–403. [PubMed] [Google Scholar]
  51. Tan E., Lynn D. J., Amato A. A., Kissel J. T., Rammohan K. W., Sahenk Z., Warmolts J. R., Jackson C. E., Barohn R. J., Mendell J. R. Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder. Arch Neurol. 1994 Feb;51(2):194–200. doi: 10.1001/archneur.1994.00540140104020. [DOI] [PubMed] [Google Scholar]
  52. Tsai C. P., Lin K. P., Liao K. K., Wang S. J., Wang V., Kao K. P., Wu Z. A. Immunosuppressive treatment in lower motor neuron syndrome with autoantibodies against GM1 ganglioside. Eur Neurol. 1993;33(6):446–449. doi: 10.1159/000116991. [DOI] [PubMed] [Google Scholar]
  53. Uncini A., Santoro M., Corbo M., Lugaresi A., Latov N. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve. 1993 Jun;16(6):610–615. doi: 10.1002/mus.880160606. [DOI] [PubMed] [Google Scholar]
  54. Van den Berg L. H., Kerkhoff H., Oey P. L., Franssen H., Mollee I., Vermeulen M., Jennekens F. G., Wokke J. H. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry. 1995 Sep;59(3):248–252. doi: 10.1136/jnnp.59.3.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Van den Bergh P., Logigian E. L., Kelly J. J., Jr Motor neuropathy with multifocal conduction blocks. Muscle Nerve. 1989 Jan;12(1):26–31. doi: 10.1002/mus.880120106. [DOI] [PubMed] [Google Scholar]
  56. Willison H. J. Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? J Neurol Neurosurg Psychiatry. 1994 Nov;57(11):1303–1307. doi: 10.1136/jnnp.57.11.1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Willison H. J., Paterson G., Kennedy P. G., Veitch J. Cloning of human anti-GM1 antibodies from motor neuropathy patients. Ann Neurol. 1994 Apr;35(4):471–478. doi: 10.1002/ana.410350416. [DOI] [PubMed] [Google Scholar]
  58. van Schaik I. N., Bossuyt P. M., Brand A., Vermeulen M. Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis. Neurology. 1995 Aug;45(8):1570–1577. doi: 10.1212/wnl.45.8.1570. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES